RT HEALTH Clinic

RT HEALTH Clinic in Waco, Texas, operates under the clinical direction of Rosalia Treto, APRN, MSN, FNP-C, delivering medically supervised weight loss programs centered on GLP-1 receptor agonist therapies. The clinic focuses exclusively on metabolic health optimization and chronic disease management through evidence-based pharmacotherapy, with particular emphasis on patients struggling with obesity-related conditions including type 2 diabetes, hypertension, and metabolic syndrome. Located in Central Texas, RT HEALTH serves Waco and surrounding McLennan County communities with in-person consultations that allow for comprehensive metabolic assessments and ongoing clinical monitoring.

The clinic's therapeutic approach centers on two FDA-approved incretin mimetics: semaglutide and tirzepatide. Semaglutide, a GLP-1 receptor agonist, works by enhancing insulin secretion, suppressing glucagon release, and slowing gastric emptying to reduce appetite and caloric intake. Tirzepatide represents a dual GIP/GLP-1 receptor agonist mechanism, activating both glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 pathways for enhanced glycemic control and weight reduction. RT HEALTH structures treatment protocols around individualized dosing schedules, beginning with conservative starter doses and titrating based on patient tolerance and metabolic response. Each medication regimen is paired with nutritional guidance and lifestyle modification strategies designed to maximize therapeutic outcomes and establish sustainable health behaviors beyond pharmacological intervention.

Rosalia Treto brings advanced practice nursing credentials with board certification as a Family Nurse Practitioner, holding both APRN licensure and a Master of Science in Nursing degree. Her clinical methodology emphasizes thorough metabolic evaluation before initiating peptide therapy, including assessment of thyroid function, insulin resistance markers, and cardiovascular risk factors that commonly accompany excess adiposity. Treto's practice model incorporates regular follow-up visits to monitor treatment response, adjust medication dosing, manage potential side effects such as gastrointestinal symptoms, and address any barriers to adherence. This hands-on approach allows for real-time clinical decision-making and ensures patients receive appropriate medical oversight throughout their weight management journey, particularly important given the metabolic complexity of obesity and related comorbidities.

Patients at RT HEALTH undergo an initial comprehensive consultation that includes medical history review, current medication assessment, weight loss goal discussion, and metabolic health evaluation. The clinic requires in-person visits for all consultations and follow-up appointments, allowing Treto to conduct physical examinations and directly assess patient progress. Treatment plans are structured around weekly or bi-weekly injectable protocols depending on the specific peptide prescribed, with patients receiving detailed injection technique training and ongoing support for medication administration. The clinic provides clear communication regarding expected timelines for weight loss, realistic goal-setting based on clinical evidence, and strategies for managing common side effects including nausea, constipation, and reduced appetite that frequently accompany GLP-1 therapy.

RT HEALTH differentiates itself through a focused clinical model that concentrates exclusively on metabolic health rather than offering a broad menu of aesthetic or wellness services. This specialization allows the clinic to maintain deep expertise in obesity medicine and chronic disease management, with protocols refined specifically for patients dealing with weight-related health complications. The Waco location provides accessible care for Central Texas residents seeking medical weight loss solutions backed by advanced pharmacotherapy, with the in-person consultation model ensuring continuity of care and direct provider-patient relationships. Treto's approach emphasizes long-term metabolic health improvement rather than rapid weight loss alone, addressing underlying insulin resistance and inflammatory markers that contribute to chronic disease progression in overweight and obese populations.